Adam Mor, MD, PhD, Assistant Professor of Medicine and Pathology at New York University School of Medicine, will discuss the role of T cells in rheumatoid arthritis.

Tracy M. Frech, MD, MS, director of the Systemic Sclerosis Clinic at the University of Utah and a rheumatologist in the Veterans Affairs Salt Lake City Health Care System, will lead the clinical symposium Systemic Sclerosis: Assessment and Treatment of Gastrointestinal Manifestations, which starts at 2:30 pm Tuesday.

Dirk Elewaut, MD, PhD, Professor of Rheumatology and Immunology and Chair of the Department of Rheumatology at Ghent University Hospital, Belgium, will discuss the role of the interleukin 23/interleukin 17 (IL23/IL17) axis in the pathogenesis of axial spondyloarthritis.